Covered recipient · General Payments record
DANIEL K MOON
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2019–2025
$6,603.85
- Reported across 43 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $500.87 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merz Pharmaceuticals, LLC | $211.33 | 3 |
| Pacira Pharmaceuticals Incorporated | $122.67 | 1 |
| ABBVIE INC. | $63.38 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $41.45 | 1 |
| DAVOL INC. | $36.11 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.03 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203121826 | CMS |
| ABBVIE INC. | $16.80 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203121830 | CMS |
| ABBVIE INC. | $16.37 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203121834 | CMS |
| ABBVIE INC. | $14.18 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203121838 | CMS |
| Boston Scientific Corporation | $41.45 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181138268 | CMS |
| Davol Inc. | $36.11 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232230403 | CMS |
| Ipsen Biopharmaceuticals, Inc | $25.93 | 05/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208837165 | CMS |
| Merz Pharmaceuticals, LLC | $67.49 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232558503 | CMS |
| Merz Pharmaceuticals, LLC | $86.01 | 10/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232558507 | CMS |
| Merz Pharmaceuticals, LLC | $57.83 | 10/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232558505 | CMS |
| Pacira Pharmaceuticals Incorporated | $122.67 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250269720 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.